Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake.
Saved in:
| Title: | Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake. |
|---|---|
| Authors: | Klemets A; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Reppo I; Department of Internal Medicine, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.; Internal Medicine Clinic of Tartu University Hospital, Tartu, Estonia., Krigul KL; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Volke V; Department of Internal Medicine, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.; Internal Medicine Clinic of Tartu University Hospital, Tartu, Estonia., Aasmets O; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia., Org E; Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia. elin.org@ut.ee. |
| Source: | Scientific reports [Sci Rep] 2026 Jan 24; Vol. 16 (1), pp. 6126. Date of Electronic Publication: 2026 Jan 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
